Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

NCT06125756 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia B Without Inhibitor

Interventions

DRUG: Low dose KL001
DRUG: Middle dose KL001
DRUG: High dose KL001

Sponsor

Affiliated Hospital of Guangdong Medical University